Metrohm USA opened its new 15,000 sq ft Houston facility on March 24, 2026, marking its shift from leased space to a custom-built, sustainable site supporting technical innovation, training, and regional growth.
Investment marks continued progress against AbbVie's $100 billion commitment to US R&D and capital investments, including manufacturing, over the next decade.
Ineos will invest €300 million, backed by French government grants, to modernise and decarbonise its Lavera site, cutting CO₂ emissions by 331,000 tons annually.
Syensqo is investing about €20 million, with backing from the France 2030 plan, to install a large-capacity electric boiler and other low-carbon infrastructure at its Saint-Fons site.
Axplora announced a multi-million-euro investment to expand lyophilization capabilities at its Le Mans site and appointed François Houbart as Head of Site.
BASF plans to open a global digital hub in Hyderabad in the first quarter of 2026, thereby strengthening the existing global network of digital hubs in EMEA and APAC.
Siegfried signed binding agreements to acquire three drug substance sites in the US and Australia.
Fluor Corporation announced the mechanical completion of BASF's landmark Zhanjiang Verbund project in China.
Tjoapack is expanding its oral solid dose (OSD) bottle packaging capabilities at its Etten-Leur, Netherlands, facility, enhancing flexibility, efficiency, and GMP-compliant packaging options to meet growing demand.
Company announces two new additional manufacturing facilities to be built in North Carolina and Pennsylvania; continues to deliver on $55 billion US investment.
AbbVie will acquire West Pharmaceutical Services’ Tempe, Arizona, manufacturing facility for over $175 million to expand US drug delivery device capacity, with closing expected mid-2026.
Sharp Sterile Manufacturing announced a $28 million expansion of its Lee, Massachusetts site to boost pharmaceutical production capacity and create high-skilled life sciences jobs.
Optex Innovation Center launches as an independent extrusion coating pilot for flexible packaging.
Carbios has reaffirmed its plan to build the Longlaville PET biorecycling plant, postponing the project by about three months while it finalizes the remaining financing in the first half of 2028.
Ineos is investing £150 million at its Grangemouth site, supported by a £75 million government loan guarantee and a £50 million grant.
Fourth major US manufacturing investment announced this year, advancing AstraZeneca’s historic $50 billion commitment to medicines manufacturing and R&D.
New capacity of specialty lubricants to accelerate business growth and innovation in the region.
New state-of-the-art facility in Philadelphia provides integrated lab and collaboration space along with tailored guidance to help move advanced therapies from early research to clinical readiness.
Novartis plans to establish a flagship manufacturing hub in North Carolina by 2027-2028 as part of a $23 billion investment in US infrastructure.
Ineos has launched a major investment at Lavera to regenerate and modernize one of France’s most important industrial sites, safeguarding 10,000 jobs, with support from the French State.
Nouryon has opened a new innovation center in Shanghai to boost localized innovation, customer collaboration, and sustainable development in key industries across China and the Asia Pacific region.
Curia has completed a $4 million upgrade to its sterile API manufacturing suites in Valladolid, Spain, to enhance product quality, safety, and regulatory compliance.
SK Pharmteco has announced a $6.1 million investment to expand its Rancho Cordova, California, facility with new lab and kilo-scale capabilities for solid-phase peptide synthesis and purification.
Aenova will install an additional filling and manufacturing line at the Latina, Italy, site. This expansion is an important step to meet the increasing global demand for the production of biologics.
Investments will bolster clinical and commercial capacity in US and Europe facilities for injectable and oral solid dose packaging, and sterile filling.
Cambrex announced a $120 million investment to expand its API manufacturing capacity at its Charles City, Iowa, facility by 40%.
The investment will focus on developing gelatin and HPMC facilities, creating over 200 new jobs, and strengthening ACG’s 25-year presence in the US, with operations expected to begin in early 2027.
The Leeds Innovation & Application Center is the newest of the now 71 Brenntag Specialties innovation centers globally, 31 of which focus on Food & Nutrition.
Roquette has inaugurated a new Pharmaceutical Innovation Center in Brazil to support advanced research and development in the region’s pharmaceutical sector.
Clariant successfully completes its CHF 100 million investment in the Daya Bay plant in China, with the second production line becoming fully operational in November.
Polyvantis has opened a new Technology Center in Shanghai, China, to unite R&D, commercial, and manufacturing teams and accelerate innovation for optical and electrical film solutions.
Fujifilm Biotechnologies has opened one of North America's largest commercial-scale cell culture biomanufacturing sites in Holly Springs, North Carolina, US.
Henkel has doubled the size of its South Dakota plant to increase production of thermal management materials for the electric vehicle and electronics markets.
Arkema has inaugurated a new laboratory in Normandy dedicated to dry coating processes for battery electrodes, aiming to advance sustainable manufacturing by reducing energy use and developing new battery solutions.
New state-of-the-art active pharmaceutical ingredient (API) facility in North Chicago will manufacture immunology, oncology, and neuroscience medicines.
